Study Evaluating The Coadministration of Begacestat And Donepezil

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Subjects

In brief

This study examines the cardiac effects (effects on the heart) of administering donepezil and begacestat together to healthy subjects.

Key facts

Study ID

NCT00959881

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

47

Starts

2009-08-01

Expected to finish

2009-11-01

Last updated by the study team

2011-04-04

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy
• Men and women of non-childbearing potential
• Non smoker or smoker of <10 cigarettes per day and able to refrain from smoking during study
• 18-50 years old

You may not qualify if…

• Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.
• Cardiac rhythm abnormalities
• Family history of cardiac risk factors

Where it is running

• Pfizer Investigational Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.